Present a conceptual model to elucidate potential mechanisms underlying cardiovascular health disparities in LGBTQ adults
Identify research gaps in both empirical data and patient populations used in trials
Provide suggestions for improving cardiovascular research and care of LGBTQ people
If you seek to deliver the best, most informed care to patients who identify as LGBTQ, this webinar is a can't-miss virtual event. Join CMHC and Dr. Streed on Wednesday, Dec. 7, 2022, from 12:30-1:30 p.m. EST.
This guest blog from Family Heart Foundation explains Jessica's journey with familial hypercholesterolemia (FH), beginning with losing her father to a heart attack at a young age and then noticing strange yellow bumps on her daughter's skin. Read more about how these clues about FH can go undetected for years, and how Family Heart Foundation seeks to educate and empower patients like Jessica to seek answers, treatment, and genetic counseling for this serious inherited disorder.
Enjoy two recordings from the recent Women's Cardiometabolic Health and Wellness Masterclass, which was held on Sept. 9, 2022, at the beautiful Terranea Resort in Southern California. If you missed the 2022 Women's Masterclass, don't fret! You can still watch the on-demand recordings from home. Purchase access here.
Watch CMHC's expert faculty and industry leaders discuss the significance of including more women leaders in cardiovascular clinical trial research. This engaging panel discussion also emphasized developing the skills, experience, and knowledge required to run a successful clinical trial so that more women can take leadership in current and future trials.
Meet Ramona Master, a board-certified internal medicine physician dedicated to providing outstanding care built on compassion and personalized attention. During this talk, she emphasizes "healing the healers" by developing mental fitness along with career and physical well-being. She highlights the need for self-compassion and self-care, which is often left behind among women physicians.
Researchers from the University of Toronto discovered that raw honey improves multiple key measures of cardiometabolic health, such as blood sugar and cholesterol levels. A systematic review and meta-analysis of clinical trials involving honey revealed that consuming honey lowers fasting blood glucose, total and LDL cholesterol, triglycerides, and a marker of fatty liver disease. Additionally, honey also appears to promote increased levels of HDL cholesterol and some inflammation markers. Although high in sugar - which is implicated in worsening cardiometabolic diseases such as diabetes and obesity - honey “is also a complex composition of common and rare sugars, proteins, organic acids and other bioactive compounds that very likely have health benefits," commented a study author.
We were delighted to see longtime CMHC faculty and Senior Planning Committee member Pamela B. Morris, MD, in the news for her cardiometabolic health research! In Lipoprotein(a) and LDL-C: The Relevance of Equivalence, published in the Journal of the American College of Cardiology, Dr. Morris and colleagues discussed the role of lipoprotein(a) in assessing atherosclerotic cardiovascular disease (ASCVD) risk in familial hypercholesterolemia (FH), in conjunction with periodic lipid panels. They write, “The weight of evidence strongly supports that both genetic lipid disorders [elevated Lp(a) levels and FH] are causally associated with an increased risk of premature ASCVD and should be carefully considered in risk assessment and management for ASCVD risk reduction. In addition to performing a lipid panel periodically according to evidence-based guidelines, measurement of Lp(a) levels should also be performed at least once in an individual’s lifetime for ASCVD risk assessment.”
